When was Alievio founded?

Alievio was founded in 2010 and raised its 1st funding round 3 years after it was founded.

Where is Alievio located?

Alievio is headquartered in Durham, United States.

How many employees does Alievio have?

As of Jun 30, 2026, the latest employee count at Alievio is 3.

Is Alievio a funded company?

Alievio is a funded company, having raised a total of $12.2M across 10 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2013.

When was the latest funding round of Alievio?

Alievio's latest funding was a $***** Series A round on Apr 09, 2018, with participation from 5 investors. Its primary sector is Ophthalmology. In United States, the Ophthalmology sector has seen $1.27B in funding in 2026 to date.

Where does Alievio rank among its competitors?

Alievio ranks 7th amongst 30 active competitors, of which 10 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Avisi Technologies, which secured $10.7M in Feb, 2026.

Who are the top competitors of Alievio?

Alievio's top competitors include Glaukos, Avisi Technologies and Myra Vision. Among them, Avisi Technologies secured the most recent funding round in February, 2026.

Alievio - 2026 Company Profile, Team, Funding & Competitors

Alievio is a series A company based in Durham (United States), founded in 2010. It operates as a Developer of a glaucoma drainage device. Alievio has raised $12.2M in funding. The company has 30 active competitors, including 10 funded and 5 that have exited. Its top competitors include companies like Glaukos, Avisi Technologies and Myra Vision.

Company Details

Alevio has developed a device for treating glaucoma to target intraocular pressure (IOP). The company has developed a small noninvasive device used to remove the intraocular pressure by draining the aqueous humor and enables the physicians to maintain the IOP by adjusting the pressure. The company claims that the outlet tube is as soft as a contact lens.

Website: alievio.com
Email ID: *****@alievio.com

Key Metrics

Founded Year

2010

Location

Durham, United States

Stage

Series A

Total Funding

$12.2M in 10 rounds

Latest Funding Round

Series A, Apr 09, 2018, $*****

Investors

VCapital & 9 more

Ranked

7^th among 30 active competitors

Employee Count

3 as on Jun 30, 2026

Similar Companies

Glaukos & 35 more

View Alievio's full profile

Alievio has raised a total funding of $12.2M over 10 rounds. Its first funding round was on Jan 01, 2013. Its latest funding round was a Series A round on Apr 09, 2018 for $*****. 5 investors participated in its latest round. Alievio has 10 institutional investors.

Here is the list of recent funding rounds of Alievio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 09, 2018	2018820	Series A	3542268	6719322	7234702	5993100
Dec 05, 2017	9036746	Series A	8410888	9387923	2492534	VCapital
Nov 27, 2017	4143998	Series A	9404252	9398690	1735735	5453744

Access funding benchmarks and valuations. Sign up today!

View details of Alievio's funding rounds and investors

Alievio's employee count trend

Alievio has 3 employees as of Jun 26. Here is Alievio's employee count trend over the years:

Uncover Alievio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alievio include Glaukos, Avisi Technologies and Myra Vision. Here is the list of Top 10 competitors of Alievio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Glaukos 2001, Laguna Hills (United States), Public	Developer of implants to treat glaucoma	$118M	Meritech, Orbimed & 9 others	70/100
2nd	Avisi Technologies 2017, Philadelphia (United States), Series A	Developer of nano-materials	$15.7M	MedVenture Partners, MedTech Innovator & 21 others	61/100
3rd	Myra Vision 2019, Campbell (United States), Series B	Developer of a medical device for the treatment of glaucoma	$42M	Cormorant Asset Management, PA MedTech VC Fund ... & 5 others	60/100
4th	Ivantis 2007, Irvine (United States), Acquired	Innovative microstent solutions for glaucoma management and surgical eye care	$166M	New Enterprise Associates, RA Capital Management ... & 8 others	49/100
5th	Sensimed 2003, Lausanne (Switzerland), Acquired	Provider of a contact lens-based glaucoma monitoring platform	$41.8M	Renaissance, Wellington Partners Venture Capital ... & 7 others	45/100
6th	New World Medical 1990, Rancho Cucamonga (United States), Unfunded	Innovating ophthalmic solutions to preserve and enhance vision for humanity	-	-	38/100
7th	Alievio 2010, Durham (United States), Series A	Developer of a glaucoma drainage device	$12.2M	VCapital, Triangle Angel Partners & 8 others	38/100
8th	Sanoculis 2012, Kiryat Ono (Israel), Series C	Provider of a surgical device for the treatment of glaucoma	$35M	DNV Capital	37/100
9th	InnFocus 2003, Miami (United States), Acquired	Ophthalmology solutions: pharmaceuticals, medical devices, research, development, production, and marketing	$49.4M	Saints Capital, Santen Pharmaceuticals & 2 others	37/100
10th	Sol 2021, San Francisco (United States), Funding Raised	Manufacturer of wearable e-readers with adjustable focus and library access	-	Initialized Capital, Crescent Ridge	37/100